You are on page 1of 2

deaths divided by the number of new cases in the same

China, Ethiopia, Myanmar, the Russian Federation and


year. The CFR allows assessment of variation in equity
Viet Nam) to limited changes (e.g. in Angola and Congo).1
in terms of access to TB diagnosis and treatment among
High TB burden countries with rates of decline in TB
countries (because if everyone with TB had access to
deaths among HIV-negative people that exceeded 6% per
timely diagnosis and high-quality treatment, the CFR
year in the 5-year period 2013–2017 included the Russian
would be low in all countries). To achieve the milestones
Federation (13% per year), Ethiopia (12% per year), Sierra
for reductions in TB deaths set for 2020 and 2025 in the
Leone (10% per year), Kenya (8% per year) and Viet Nam
End TB Strategy, the global CFR needs to fall to 10% by
(8% per year).
2020 and to 6.5% by 2025 (Chapter 2).
Globally, the number of TB deaths among HIV-positive
people has fallen by 44% since 2000, from 534 000 In 2017, the global CFR (calculated as the combined
(range, 460 000–613 000) in 2000 to 300 000 (range, number of TB deaths in HIV-negative people and HIV-
266 000–335 000) in 2017, and by 20% since 2015. Most positive people, divided by the total number of incident
of this reduction was in the WHO African Region (Fig. cases in both HIV-negative and HIV-positive people)2 was
3.15). In several high TB burden countries, the number 16%, down from 23% in 2000. It varied widely among

GLOBAL TUBERCULOSIS REPORT 2018


countries (Fig. 3.17), from under 5% in a few countries
of deaths caused by TB among HIV-positive people has
to more than 20% in most countries in the WHO African
fallen substantially in recent years; for example, in
Region. Intensified efforts are required to reduce the CFR
Cambodia, Kenya, Namibia, South Africa, the United
Republic of Tanzania and Zimbabwe (Fig. 3.16). to 10% globally by 2020.

3.2.3 The case fatality ratio and across-country

You might also like